Antonio Valero

3.9k total citations
113 papers, 2.6k citations indexed

About

Antonio Valero is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Antonio Valero has authored 113 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Physiology, 64 papers in Immunology and Allergy and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Antonio Valero's work include Asthma and respiratory diseases (70 papers), Allergic Rhinitis and Sensitization (58 papers) and Respiratory and Cough-Related Research (19 papers). Antonio Valero is often cited by papers focused on Asthma and respiratory diseases (70 papers), Allergic Rhinitis and Sensitization (58 papers) and Respiratory and Cough-Related Research (19 papers). Antonio Valero collaborates with scholars based in Spain, United States and Colombia. Antonio Valero's co-authors include Joaquim Mullol, Joan Bartra, César Picado, Rosa Muñoz‐Cano, J. Sastre, Isam Alobid, Ignacio Dávila, Marta Ferrer, I Jáuregui and A del Cuvillo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The FASEB Journal.

In The Last Decade

Antonio Valero

110 papers receiving 2.5k citations

Peers

Antonio Valero
Robert M. Naclerio United States
Elina Toskala United States
Philip Lieberman United States
Robert J. Dockhorn United States
Jennifer Maloney United States
Howard M. Druce United States
Tae Hoon Kim South Korea
Antonio Valero
Citations per year, relative to Antonio Valero Antonio Valero (= 1×) peers G. Passalacqua

Countries citing papers authored by Antonio Valero

Since Specialization
Citations

This map shows the geographic impact of Antonio Valero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Valero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Valero more than expected).

Fields of papers citing papers by Antonio Valero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Valero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Valero. The network helps show where Antonio Valero may publish in the future.

Co-authorship network of co-authors of Antonio Valero

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Valero. A scholar is included among the top collaborators of Antonio Valero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Valero. Antonio Valero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muñoz‐Cano, Rosa, et al.. (2024). Differential healthcare direct costs of asthma and chronic rhinosinusitis with nasal polyps in Catalonia (Spain). Rhinology Journal. 0(0). 0–0. 1 indexed citations
2.
Caruso, Cristiano, Giorgio Walter Canonica, Manish Patel, et al.. (2024). Prospective REALITI-A Study. SHILAP Revista de lepidopterología. 3(1). 100107–100107. 3 indexed citations
3.
Roca‐Ferrer, Jordi, Isam Alobid, Mireya Fuentes, et al.. (2023). Upregulation of Platelet-Activating Factor Receptor Expression and Lyso-Platelet-Activating Factor Isoforms in Human Nasal Polyp Tissues. Journal of Clinical Medicine. 12(23). 7357–7357. 1 indexed citations
4.
Molina, Jesús, et al.. (2023). Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study. SHILAP Revista de lepidopterología. 5(2). 100232–100232. 3 indexed citations
5.
Valero, Antonio, Elizabeth García, Augusto Peñaranda, et al.. (2022). Control of allergic rhinitis in four latin american countries: Rinola study. SHILAP Revista de lepidopterología. 3. 980515–980515. 3 indexed citations
6.
7.
Navarro, Ana, C. Colás, A del Cuvillo, et al.. (2020). Validation of the DECA criteria for allergic conjunctivitis severity and control. Clinical and Translational Allergy. 10(1). 43–43. 6 indexed citations
8.
Jáuregui, I, Ana M. Giménez‐Arnau, Joan Bartra, et al.. (2019). Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study). Health and Quality of Life Outcomes. 17(1). 23–23. 7 indexed citations
9.
Izquierdo-Domínguez, Adriana, I Jáuregui, A del Cuvillo, et al.. (2017). Allergy rhinitis: similarities and differences between children and adults. Rhinology Journal. 55(4). 326–331. 20 indexed citations
10.
Muñoz‐Cano, Rosa, Mariona Pascal, M. J. Goikoetxea, et al.. (2017). Mechanisms, Cofactors, and Augmenting Factors Involved in Anaphylaxis. Frontiers in Immunology. 8. 1193–1193. 59 indexed citations
11.
Cuvillo, A del, Víctor Sacristán Santos, J Montoro, et al.. (2017). Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe. Rhinology Journal. 55(1). 34–38. 31 indexed citations
12.
Balañá, M, et al.. (2015). Validation of The Spanish Version of The Urticaria Activity Score (Uas) and Its Use Over One Week (Uas7). Value in Health. 18(7). A426–A426. 5 indexed citations
13.
Sánchez-López, J, et al.. (2015). Desensitization to rituximab in a multidisciplinary setting. International Journal of Clinical Pharmacy. 37(5). 744–748. 7 indexed citations
14.
Valero, Antonio, Rosa Muñoz‐Cano, J. Sastre, et al.. (2012). The impact of allergic rhinitis on symptoms, and quality of life using the new criterion of ARIA severity classification. Rhinology Journal. 50(1). 33–36. 21 indexed citations
15.
Mullol, Joaquim, Isam Alobid, Franklin Mariño‐Sánchez, et al.. (2012). Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study). BMJ Open. 2(6). e001256–e001256. 161 indexed citations
16.
Yepes-Núñez, Juan José, Joan Bartra, Rosa Muñoz‐Cano, et al.. (2012). Assessment of nasal obstruction: Correlation between subjective and objective techniques. Allergologia et Immunopathologia. 41(6). 397–401. 59 indexed citations
17.
Zoccatelli, Gianni, Kay Foetisch, Joan Bartra, et al.. (2010). Identification and characterization of the major allergen of green bean (Phaseolus vulgaris) as a non-specific lipid transfer protein (Pha v 3). Molecular Immunology. 47(7-8). 1561–1568. 27 indexed citations
18.
Guilemany, J.M., Isam Alobid, Silvia Centellas, et al.. (2009). Persistent allergic rhinitis has a moderate impact on the sense of smell, depending on both nasal congestion and inflammation. The Laryngoscope. 119(2). 233–238. 72 indexed citations
19.
Navarro, Ana, C. Colás, E. Antón, et al.. (2009). Epidemiology of allergic rhinitis in allergy consultations in Spain: Alergológica-2005.. PubMed. 19 Suppl 2. 7–13. 46 indexed citations
20.
Fraj, J., et al.. (2007). Safety of triflusal (antiplatelet drug) in patients with aspirin‐exacerbated respiratory diseases. Allergy. 63(1). 112–115. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026